Summer Ng was 24 years old when she was diagnosed with cervical cancer and told she could not become a mother. In this candid fireside chat with Yvonne Ng, founder of the Alliance for Active Action Against HPV (A4HPV), Summer discusses her experience of coping with the diagnosis and charting a path through a medical […]
Cervical cancer survivor shares journey from diagnosis to recovery Read More »
To find out more about the Karen Leung Foundation and the work they do, please click here. In Hong Kong, cervical cancer ranked as the 8th most common cancer and cause of mortality amongst women in 2019 [1]. Despite a national screening programme implemented in 2004, studies show that close to 40% of women
Advancing women’s health: Project Teal drives cervical cancer screening in Hong Kong Read More »
This article is part of a series on diagnostics within Women’s Health. We’ll be adding more stories and related content throughout the year. Check out the first story in this series about cervical cancer triage testing here. On Jan 28, cervical cancer experts from across the Asia Pacific region and around the world came together
APEC policy dialogue on cervical cancer management highlights role of clinical labs Read More »
Compared to traditional immunohistochemistry (IHC) and protein staining techniques, many pathologists prefer bright-field chromogenic or silver-enhanced in situ hybridization (ISH) staining more than fluorescence ISH, because it provides more stable results that can be reviewed over time without fears of degradation. In a recent webinar hosted by Roche Diagnostics Asia Pacific, two Australian pathologists discussed
HER2 DISH assay showcases value of image analysis algorithms Read More »
Of the many specialty areas for which clinical labs are implementing digital pathology, breast cancer is among the most common — and one of the applications where digital pathology has been the most helpful. The ability to perform whole-slide imaging has been valuable for samples with highly heterogeneous tissue and in light of the increasing
For breast cancer analysis, digital pathology offers a streamlined approach Read More »
To learn more about how cervical cancer impacts the lives of women globally and the steps organisations are taking to eliminate this disease globally, please visit the Conquering Cancer campaign. Click here for videos related to the campaign. This article is part of a new series on diagnostics within Women’s Health. We’ll be adding more
Ava is a women’s health company that provides digital tools to help women ensure optimal fertility and navigate the reproductive journey. In this presentation, Ava CEO and Co-Founder Ms Lea von Bidder shares updates on her company’s efforts to leverage big data and wearable technology in order to make fertility planning more personalised and successful.
How Ava Women supports fertility planning with digital health Read More »
Hear from Ms Noren Suseno, a breast cancer survivor and member of the Breast Cancer Foundation, Singapore, as she shares her journey from diagnosis to treatment and recovery. Ms Suseno also talks about the work that the Foundation provides for its members, including their efforts to improve early breast cancer detection and support for the
Cervical cancer is the 4th leading type of cancer amongst women in the world. Caused by human papillomavirus (HPV) infection, cervical cancer is highly preventable through the use of prophylactic measures like HPV vaccines and robust screening programmes. Through the launch of the Global Strategy to Accelerate the Elimination of Cervical Cancer in late 2020,
HPV screening and vaccination in Asia: overcoming barriers to access Read More »
Listen to perspectives from Professor Tan Puay Hoon, Senior Consultant Histopathologist and Chairman of the Division of Pathology at Singapore General Hospital, as she discusses triple negative breast cancer from a pathologist’s standpoint. In this recent webinar supported by the Singapore Society of Oncology, Prof Tan highlights the WHO guidelines for evaluating tumour infiltrating lymphocytes
A pathologist’s perspective on triple negative breast cancer Read More »
Subscribe to Lab Insights latest news and update
Join over 3,000 HCPs receiving insights in their inbox.
